Thoracic epidural anaesthesia alone is an applied technique of anaesthesia for nephrectomy which has both advantages and limitations. Dexmedetomidine is a highly selective α 2 -adrenoreceptor agonist which has both central and peripheral analgesic properties. Forty patients undergoing nephrectomy were enrolled in this clinical trial and allocated randomly to two groups, a control group (C group) and a dexmedetomidine group (D group). The C group received epidural 0.75% levobupivacaine 12 ml with 1 ml of isotonic sodium chloride solution, while the D group received epidural 0.75% levobupivacaine 12 ml with 1 ml (0.5 μg/kg) of dexmedetomidine. Haemodynamic changes, onset time and duration of sensory and motor block, muscle relaxation score, verbal rating score for pain, sedation score and the total postoperative analgesic consumption were evaluated. Sensory blockade duration was longer in the D group than in the C group (P=0.01). The incidence of motor block and the muscle relaxation score were significantly higher in the D group compared with the C group (P=0.01).
Nephrectomy can be performed under general anaesthesia, combined general anaesthesia and thoracic epidural anaesthesia or thoracic epidural anaesthesia alone 1 . Compared with alternative anaesthetic techniques, epidural anaesthesia may reduce the risks of venous thromboembolism, myocardial infarction, bleeding complications, pneumonia, respiratory depression and renal failure 2 . Various investigators have demonstrated the benefits of epidural anaesthesia [3] [4] [5] [6] , which nevertheless also has limitations, including patient anxiety, unsatisfactory sedation, insufficient muscle relaxation and intraoperative pain. An epidural adjuvant that provides stable haemodynamics, good sedation and ideal postoperative analgesia, thus resolving the above-mentioned limitations, is in great demand.
Clonidine, an α 2 -adrenoreceptor agonist, has been used as such an adjuvant, and some studies have found that clonidine prolongs the duration of spinal block and postoperative analgesia 7, 8 but causes dose-dependent hypotension within the therapeutic range 9, 10 . In the last few years, dexmedetomidine has been administered perineurally in combination with local anaesthetics for nerve conduction block [11] [12] [13] and intravenously (IV) during spinal or epidural anaesthesia 14, 15 . There are data on the neuraxial use of dexmedetomidine and its side-effects in humans [16] [17] [18] [19] [20] [21] [22] . In these studies, dexmedetomidine potentiated anaesthesia and had few sideeffects. Compared with clonidine, dexmedetomidine may be a more effective analgesic and it may avoid the undesirable cardiovascular effects related to α 1 -adrenoreceptor activation 23 because of its high selectivity for α 2 -adrenoreceptors. Intrathecal dexmedetomidine and clonidine, used in a 1:10 dose ratio, have similar effects in terms of duration and block characteristics, but the duration of postoperative analgesia is greater after dexmedetomidine 22 .
Compared with systemic administration, neuraxial administration of dexmedetomidine has advantages. The α 2 -adrenoreceptor agonist has a direct effect on peripheral nerve activity 19, 24 . Due to its lipophilicity, dexmedetomidine rapidly appears in the cerebrospinal fluid and reaches binding sites in the spinal cord after epidural administration, and its analgesic effect is up to five times greater with epidural rather than systemic administration 25 . It exhibits a spinally mediated antinociceptive effect when administered intrathecally in animals and the same dose has no effect when given systemically 26 . Another animal study further showed the advantages of epidural administration, in that an IV dose of almost 10 μg/ kg achieved maximal analgesia but an epidural dose of only 3.3 μg/kg had a similar but longer lasting analgesic effect 27 .
Given these benefits, epidural dexmedetomidine appears well suited to use in epidural-only anaesthesia. We speculated that dexmedetomidine would improve the anaesthetic quality of levobupivacaine-induced thoracic epidural anaesthesia, making this a suitable anaesthetic technique for open nephrectomy. Because high doses of dexmedetomidine may lead to hypotension, bradycardia or neurotoxicity [28] [29] [30] , lowdose dexmedetomidine was chosen.
MATeRIALS AND MeTHoDS

Study subjects
This prospective, randomised, double-blind, placebo-controlled trial was approved by the ethics or less than 19 kg/m 2 , renal or hepatic insufficiency, known allergy to amide local anaesthetic, neurologic or psychiatric disease, bleeding or coagulation test abnormalities, or were receiving anticoagulant or sedative drugs.
Study treatment and procedures
Using a computer program generating an odd and even number sequence, the patients were randomly divided into two groups: a control group (C group, n=20) and a dexmedetomidine group (D group, n=20). An 18-gauge cannula was inserted to infuse lactated Ringer's solution at a rate of 6 to 15 ml/kg/hour. All patients received midazolam 2 mg IV and fentanyl 50 µg IV five minutes before epidural anaesthesia was performed. Baseline measurements included heart rate (HR), non-invasive arterial blood pressure, respiratory rate and peripheral oxygen saturation. The epidural catheter was placed in the T9/10 interspace using a midline approach. The epidural space was identified by loss of resistance to saline and a test dose of 2% lignocaine with 1:200,000 adrenaline 3 ml to detect intrathecal or intravascular misplacement. Thirteen millilitres of solution was administrated to patients in each group, the C group receiving 0.75% levobupivacaine 12 ml plus 1 ml of preservative-free normal saline and the D group receiving 0.75% levobupivacaine 12 ml plus 1 ml of dexmedetomidine (0.5 μg/kg). The latter was drawn up using a 1 ml tuberculin syringe with 0.01 ml markings prior to dilution in preservative-free normal saline to 1 ml. Sensory block was assessed by pinprick testing and motor block of L1/2 nerve roots was evaluated by testing hip flexion power. Onset time was defined as the interval between the completion of administration of epidural local anaesthetic and the sensory block level reaching T4. The patient was given a single dose of fentanyl 50 μg IV if they suffered intraoperative pain. If anaesthesia was unreliable or proved unsatisfactory for surgery it was considered to have There were no statistically significant differences between the two groups. Descriptive data are mean and SD. F=female, M=male, SD=standard deviation. failed. Such patients were given general anaesthesia and excluded from the study.
Assessments
To maintain blinding, the anaesthetist who prepared the study solution did not perform the epidural and was not involved in management or assessments. HR, systolic arterial blood pressure, diastolic arterial blood pressure and mean arterial pressure were recorded at baseline and 5, 10, 15, 30, 45, 60 and 90 minutes after the injection of the study solution. Adverse events, including hypotension (mean arterial pressure >30% from baseline for 60 seconds), bradycardia (HR <50 beats per minute), hypoxaemia (peripheral oxygen saturation <90%), shivering, and nausea and vomiting were recorded, along with the duration of sensory block (defined as the time between the epidural injection and the complete resolution of anaesthesia) and the incidence of motor block. The level of abdominal muscle relaxation was assessed by the surgeon using a three-point scale: 0=poor, 1=acceptable, 2=perfect. Patients with a score of 0 were converted to general anaesthesia. For postoperative analgesia, patients received morphine 0.03 mg/kg through the epidural catheter at the end of the procedure.
The patients' level of sedation was assessed using the Ramsay scale (1 to 6) and postoperative pain was measured using an 11-point verbal rating score (0 to 10). Postoperative analgesic requirements were met with IV flurbiprofen 100 mg on patient request. The total dose of flurbiprofen administered was recorded, as were vital signs every 30 minutes for six hours. Sedation and pain scores and nerve function were assessed 2, 4, 6 and 24 hours after surgery. Sideeffects related to dexmedetomidine were recorded.
Statistical analysis
The sample size was calculated using a power analysis based on the mean and standard deviation observed in a pilot study (mean: 322 minutes [C group] and 449 minutes [D group]; standard deviation: 106 minutes) and the desire to detect a difference in the duration of sensory block, with alpha set at 0.05 and beta at 0.1 (one-sided hypothesis). Thirteen patients were required in each group, with 20 patients per group recruited to compensate for possible dropouts and protocol breaches. Data were tested for normal distribution using the Kolmogorov-Smirnov test. Parametric data were described as mean and standard deviation and non-parametric data as median and interquartile range. gender, incidence of motor block and the incidence of complications were analysed using the chi-square test. The Kruskal-Wallis test was used to compare sedation, muscle relaxation and pain scores between groups. For the other variables showing a normal distribution, an independent twosample t-test was used for intergroup comparison. P <0.05 was considered statistically significant. All statistical analyses were performed using SPSS 19.0 software (IBM ® , Armonk, NY, USA).
ReSULTS
Forty patients were screened and all met study criteria. one subject in the C group was excluded because of inadequate intraoperative analgesia, leaving 39 patients. There were no statistically significant differences between the two groups with respect to demographic data and surgical characteristics ( Table 1) .
Patients in the C group received a higher dose of intraoperative fentanyl ( Table 2 , P=0.02). The onset time of sensory block was not significantly different between groups but sensory block duration was longer in the D group than in the C group (Table 2 , P=0.01). The incidence of motor block was significantly higher in the D group (75% versus 20%, P=0.01). The muscle relaxation score (median, interquartile range) was higher in the D group (2, 2 to 2 versus 1, 1.25 to 1.75, P=0.01).
There was no significant difference between groups for systolic arterial blood pressure or diastolic arterial blood pressure (Figure 1 ), but HR was significantly lower in the D group at 5, 10, 15, 30 and 45 minutes (Figure 1 , 5 minutes P=0.001; 10 minutes P=0.005; 15 minutes P=0.035; 30 minutes P=0.009; 45 minutes P=0.049). No cases of bradycardia required intervention. There were no significant differences between the groups in the incidence of nausea, vomiting, shivering or postoperative vital signs.
Compared with the C group, the D group pain score was significantly lower during the first four hours after surgery (Figure 2, 2 hours rest P=0.038; 2 hours activity P=0.009; 4 hours rest P=0.044; 4 hours activity P=0.003). The dose of flurbiprofen used was significantly lower in the D group than in the C group (Table 2 , P=0.03). Sedation scores during the operative period were significantly higher in the D group (3, 3 to 3 versus 2.5, 2.25 to 2.75, P=0.03), but there were no significant differences during the postoperative period.
DISCUSSIoN
This study showed that a low dose of epidural dexmedetomidine (0.5 μg/kg) prolongs the duration of sensory blockade and improves the quality of motor blockade during levobupivacaine thoracic epidural anaesthesia. Adequate sedation and less intraoperative breakthrough pain were also noted. This dose of dexmedetomidine, which was lower than that used in previous studies 16, [31] [32] [33] , did not cause sideeffects such as hypotension, bradycardia or neurologic deficits. The addition of dexmedetomidine facilitated successful open nephrectomy under thoracic epidural anaesthesia alone, a technique not widely used before.
The results of our study were partly consistent with a previous study conducted on patients undergoing hernia repair or varicose vein surgery under epidural anaesthesia, in which dexmedetomidine 1.0 μg/kg was combined with 0.75% ropivacaine. In this study dexmedetomidine prolonged sensory blockade during the surgical procedure, this being consistent with other studies 31, 32 . Previous research has focused on lower abdominal or lower limb surgery, but our study demonstrated that this method of anaesthesia is also suitable for mid-abdominal surgery. Some previous investigations have demonstrated that peripheral or epidural administration of dexmedetomidine can shorten the onset time of sensory block 11, 32 , but other studies have reached the opposite conclusion 12, 16, 34 . We found no effect on the onset time of sensory block and postulate this may have been due to the use of a low dose via the epidural route.
Dexmedetomidine intensifies motor block 11, 16, 32 and because of the strong relationship between motor block and muscle relaxation, procedures can be performed under near ideal conditions when dexmedetomidine is included, as confirmed by the muscle relaxation scores given by the surgeon. 
VRS
Postoperative hour
Due to high lipid solubility, epidural dexmedetomidine is absorbed into the circulation, leading to systemic effects such as sedation 27 . In our study, the sedation score was only higher in the dexmedetomidine group during the operative period, a time when this can be beneficial. Sedative and perineural analgesic effects may have contributed to the better intraoperative conditions among patients given dexmedetomidine. Various studies have evaluated the effects of dexmedetomidine on postoperative analgesia 16, 32 . In this study, a dexmedetomidine dose of 0.5 µg/kg produced a significant but clinically unimportant reduction in the very early pain scores and analgesic requirements, possibly due to inhibition of the release of peptides from the spinal cord, inhibition of dorsal horn nociceptive neurons and the prolonged duration of sensory block. The α 2C -adrenoreceptor may mediate α 2 -agonist analgesia and be synergistic with spinal cord opioid analgesia 35 .
It is known that dexmedetomidine can cause hypotension and bradycardia when used in high doses 12, 28, 34 . Perhaps because of the lower dose used in our study, we did not observe any significant haemodynamic changes and, of note, bradycardia did not occur, despite the HR being significantly lower than among controls for up to 45 minutes after administration of the epidural study solution.
Levobupivacaine, dexmedetomidine and sodium chloride, without preservatives, were administered epidurally. There are limited human data about epidural or intrathecal dexmedetomidine, so the safety of dexmedetomidine in epidural anaesthesia remains debatable. However, a number of studies have used peripheral, intrathecal or epidural injection without reporting neurologic deficits 12, 16, [18] [19] [20] [21] [22] 34 and some administered higher epidural doses than used in our research. If safety is dose-related, the lowest effective doses for different surgical procedures need to be identified. Animal experiments support the safety of intrathecal dexmedetomidine, which shows no significant pathological impact on the spinal cord: on the contrary, it may have protective effects against lignocaine-induced neural cell death 36 . one animal experiment found that epidural dexmedetomidine was harmful to the myelin sheath, possibly related to the pH of the dexmedetomidine 30 . Local anaesthetic solutions of low pH were suspected to cause neurotoxicity, although this notion was subsequently discredited 37 .
We did not measure the plasma concentration of dexmedetomidine or compare IV and epidural administration. Inclusion of an IV dexmedetomidine group would have helped to determine whether the effects of epidural dexmedetomidine are local or systemic. The time to the first administration of analgesic is an important clinical outcome which we did not record and the mechanism by which sensory block is prolonged by dexmedetomidine was not evaluated.
Despite these limitations, our research highlights the benefit of epidural dexmedetomidine 0.5 µg/kg as an adjunct to thoracic epidural anaesthesia with levobupivacaine for nephrectomy. This may prove especially useful for patients with comorbid disease that relatively contraindicates general anaesthesia.
ReFeReNCeS
